The global Targeted Radionuclide Therapy market was valued at US$ 1043 million in 2023 and is anticipated to reach US$ 4471.9 million by 2030, witnessing a CAGR of 17.4% during the forecast period 2024-2030.

Targeted Radionuclide Therapy Market

Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.

The key drivers of the radioimmunotherapy market is its potential to deliver highly targeted and precise treatment to cancer cells, sparing healthy tissues and reducing side effects compared to traditional radiation therapies. The ability of RIT to offer personalized treatment options based on specific cancer biomarkers further enhances its appeal in the field of precision medicine. However, the radioimmunotherapy market also faces challenges. One major challenge is the high cost associated with the development and production of radiopharmaceuticals, limiting access for some patients and healthcare systems. Additionally, navigating complex regulatory pathways for approval and reimbursement of RIT products can be time-consuming and resource-intensive for pharmaceutical companies. Furthermore, there may be limited awareness and acceptance of RIT among healthcare professionals and patients, leading to slower adoption rates and market penetration. Addressing these challenges requires continued research and investment in RIT technologies to improve efficacy and cost-effectiveness. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can facilitate knowledge-sharing and streamline the regulatory process.

This report aims to provide a comprehensive presentation of the global market for Targeted Radionuclide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Radionuclide Therapy.

Report Scope

The Targeted Radionuclide Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Radionuclide Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Targeted Radionuclide Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Targeted Radionuclide Therapy Market Report

Report Metric	Details
Report Name	Targeted Radionuclide Therapy Market
Accounted market size in 2023	US$ 1043 million
Forecasted market size in 2030	US$ 4471.9 million
CAGR	17.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Beta-emitting Targeted Alpha Therapy
Segment by Application	Solid Tumor Non Hodgkin Lymphoma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Radionuclide Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Targeted Radionuclide Therapy Market growing?

Ans: The Targeted Radionuclide Therapy Market witnessing a CAGR of 17.4% during the forecast period 2024-2030.

What is the Targeted Radionuclide Therapy Market size in 2030?

Ans: The Targeted Radionuclide Therapy Market size in 2030 will be US$ 4471.9 million.

Who are the main players in the Targeted Radionuclide Therapy Market report?

Ans: The main players in the Targeted Radionuclide Therapy Market are Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, Gilead Sciences, Clarity Pharmaceuticals, Curasight, Nordic Nanovector, Philogen, RadioMedix, Telix Pharmaceuticals, Orano Med, Actinium Pharmaceuticals, Y-mAbs Therapeutics, Fusion Pharmaceuticals

What are the Application segmentation covered in the Targeted Radionuclide Therapy Market report?

Ans: The Applications covered in the Targeted Radionuclide Therapy Market report are Solid Tumor, Non Hodgkin Lymphoma

What are the Type segmentation covered in the Targeted Radionuclide Therapy Market report?

Ans: The Types covered in the Targeted Radionuclide Therapy Market report are Beta-emitting, Targeted Alpha Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted Radionuclide Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Beta-emitting

1.2.3 Targeted Alpha Therapy

1.3 Market by Application

1.3.1 Global Targeted Radionuclide Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Solid Tumor

1.3.3 Non Hodgkin Lymphoma

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted Radionuclide Therapy Market Perspective (2019-2030)

2.2 Targeted Radionuclide Therapy Growth Trends by Region

2.2.1 Global Targeted Radionuclide Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Targeted Radionuclide Therapy Historic Market Size by Region (2019-2024)

2.2.3 Targeted Radionuclide Therapy Forecasted Market Size by Region (2025-2030)

2.3 Targeted Radionuclide Therapy Market Dynamics

2.3.1 Targeted Radionuclide Therapy Industry Trends

2.3.2 Targeted Radionuclide Therapy Market Drivers

2.3.3 Targeted Radionuclide Therapy Market Challenges

2.3.4 Targeted Radionuclide Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted Radionuclide Therapy Players by Revenue

3.1.1 Global Top Targeted Radionuclide Therapy Players by Revenue (2019-2024)

3.1.2 Global Targeted Radionuclide Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Targeted Radionuclide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Targeted Radionuclide Therapy Revenue

3.4 Global Targeted Radionuclide Therapy Market Concentration Ratio

3.4.1 Global Targeted Radionuclide Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted Radionuclide Therapy Revenue in 2023

3.5 Targeted Radionuclide Therapy Key Players Head office and Area Served

3.6 Key Players Targeted Radionuclide Therapy Product Solution and Service

3.7 Date of Enter into Targeted Radionuclide Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Radionuclide Therapy Breakdown Data by Type

4.1 Global Targeted Radionuclide Therapy Historic Market Size by Type (2019-2024)

4.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2025-2030)

5 Targeted Radionuclide Therapy Breakdown Data by Application

5.1 Global Targeted Radionuclide Therapy Historic Market Size by Application (2019-2024)

5.2 Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Targeted Radionuclide Therapy Market Size (2019-2030)

6.2 North America Targeted Radionuclide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Targeted Radionuclide Therapy Market Size by Country (2019-2024)

6.4 North America Targeted Radionuclide Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted Radionuclide Therapy Market Size (2019-2030)

7.2 Europe Targeted Radionuclide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Targeted Radionuclide Therapy Market Size by Country (2019-2024)

7.4 Europe Targeted Radionuclide Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Targeted Radionuclide Therapy Market Size (2019-2030)

8.2 Asia-Pacific Targeted Radionuclide Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Targeted Radionuclide Therapy Market Size (2019-2030)

9.2 Latin America Targeted Radionuclide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Targeted Radionuclide Therapy Market Size by Country (2019-2024)

9.4 Latin America Targeted Radionuclide Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted Radionuclide Therapy Market Size (2019-2030)

10.2 Middle East & Africa Targeted Radionuclide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Targeted Radionuclide Therapy Introduction

11.1.4 Bayer Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.1.5 Bayer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Targeted Radionuclide Therapy Introduction

11.2.4 Novartis Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Lantheus

11.3.1 Lantheus Company Detail

11.3.2 Lantheus Business Overview

11.3.3 Lantheus Targeted Radionuclide Therapy Introduction

11.3.4 Lantheus Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.3.5 Lantheus Recent Development

11.4 Aurobindo Pharma

11.4.1 Aurobindo Pharma Company Detail

11.4.2 Aurobindo Pharma Business Overview

11.4.3 Aurobindo Pharma Targeted Radionuclide Therapy Introduction

11.4.4 Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.4.5 Aurobindo Pharma Recent Development

11.5 Mundipharma

11.5.1 Mundipharma Company Detail

11.5.2 Mundipharma Business Overview

11.5.3 Mundipharma Targeted Radionuclide Therapy Introduction

11.5.4 Mundipharma Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.5.5 Mundipharma Recent Development

11.6 China Isotope & Radiation

11.6.1 China Isotope & Radiation Company Detail

11.6.2 China Isotope & Radiation Business Overview

11.6.3 China Isotope & Radiation Targeted Radionuclide Therapy Introduction

11.6.4 China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.6.5 China Isotope & Radiation Recent Development

11.7 Curium Pharmaceuticals

11.7.1 Curium Pharmaceuticals Company Detail

11.7.2 Curium Pharmaceuticals Business Overview

11.7.3 Curium Pharmaceuticals Targeted Radionuclide Therapy Introduction

11.7.4 Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.7.5 Curium Pharmaceuticals Recent Development

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Detail

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences Targeted Radionuclide Therapy Introduction

11.8.4 Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.8.5 Gilead Sciences Recent Development

11.9 Clarity Pharmaceuticals

11.9.1 Clarity Pharmaceuticals Company Detail

11.9.2 Clarity Pharmaceuticals Business Overview

11.9.3 Clarity Pharmaceuticals Targeted Radionuclide Therapy Introduction

11.9.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.9.5 Clarity Pharmaceuticals Recent Development

11.10 Curasight

11.10.1 Curasight Company Detail

11.10.2 Curasight Business Overview

11.10.3 Curasight Targeted Radionuclide Therapy Introduction

11.10.4 Curasight Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.10.5 Curasight Recent Development

11.11 Nordic Nanovector

11.11.1 Nordic Nanovector Company Detail

11.11.2 Nordic Nanovector Business Overview

11.11.3 Nordic Nanovector Targeted Radionuclide Therapy Introduction

11.11.4 Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.11.5 Nordic Nanovector Recent Development

11.12 Philogen

11.12.1 Philogen Company Detail

11.12.2 Philogen Business Overview

11.12.3 Philogen Targeted Radionuclide Therapy Introduction

11.12.4 Philogen Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.12.5 Philogen Recent Development

11.13 RadioMedix

11.13.1 RadioMedix Company Detail

11.13.2 RadioMedix Business Overview

11.13.3 RadioMedix Targeted Radionuclide Therapy Introduction

11.13.4 RadioMedix Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.13.5 RadioMedix Recent Development

11.14 Telix Pharmaceuticals

11.14.1 Telix Pharmaceuticals Company Detail

11.14.2 Telix Pharmaceuticals Business Overview

11.14.3 Telix Pharmaceuticals Targeted Radionuclide Therapy Introduction

11.14.4 Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.14.5 Telix Pharmaceuticals Recent Development

11.15 Orano Med

11.15.1 Orano Med Company Detail

11.15.2 Orano Med Business Overview

11.15.3 Orano Med Targeted Radionuclide Therapy Introduction

11.15.4 Orano Med Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.15.5 Orano Med Recent Development

11.16 Actinium Pharmaceuticals

11.16.1 Actinium Pharmaceuticals Company Detail

11.16.2 Actinium Pharmaceuticals Business Overview

11.16.3 Actinium Pharmaceuticals Targeted Radionuclide Therapy Introduction

11.16.4 Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.16.5 Actinium Pharmaceuticals Recent Development

11.17 Y-mAbs Therapeutics

11.17.1 Y-mAbs Therapeutics Company Detail

11.17.2 Y-mAbs Therapeutics Business Overview

11.17.3 Y-mAbs Therapeutics Targeted Radionuclide Therapy Introduction

11.17.4 Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.17.5 Y-mAbs Therapeutics Recent Development

11.18 Fusion Pharmaceuticals

11.18.1 Fusion Pharmaceuticals Company Detail

11.18.2 Fusion Pharmaceuticals Business Overview

11.18.3 Fusion Pharmaceuticals Targeted Radionuclide Therapy Introduction

11.18.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024)

11.18.5 Fusion Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

China Isotope & Radiation

Curium Pharmaceuticals

Gilead Sciences

Clarity Pharmaceuticals

Telix Pharmaceuticals

Orano Med

Actinium Pharmaceuticals

Y-mAbs Therapeutics

Fusion Pharmaceuticals

List of Tables

Table 1. Global Targeted Radionuclide Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Beta-emitting

Table 3. Key Players of Targeted Alpha Therapy

Table 4. Global Targeted Radionuclide Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Targeted Radionuclide Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Targeted Radionuclide Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Targeted Radionuclide Therapy Market Share by Region (2019-2024)

Table 8. Global Targeted Radionuclide Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Targeted Radionuclide Therapy Market Share by Region (2025-2030)

Table 10. Targeted Radionuclide Therapy Market Trends

Table 11. Targeted Radionuclide Therapy Market Drivers

Table 12. Targeted Radionuclide Therapy Market Challenges

Table 13. Targeted Radionuclide Therapy Market Restraints

Table 14. Global Targeted Radionuclide Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Targeted Radionuclide Therapy Market Share by Players (2019-2024)

Table 16. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2023)

Table 17. Ranking of Global Top Targeted Radionuclide Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Targeted Radionuclide Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Targeted Radionuclide Therapy Product Solution and Service

Table 21. Date of Enter into Targeted Radionuclide Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Targeted Radionuclide Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Targeted Radionuclide Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Targeted Radionuclide Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Targeted Radionuclide Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Targeted Radionuclide Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Targeted Radionuclide Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Targeted Radionuclide Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Targeted Radionuclide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Targeted Radionuclide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Targeted Radionuclide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Targeted Radionuclide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Targeted Radionuclide Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Targeted Radionuclide Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Targeted Radionuclide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Targeted Radionuclide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Targeted Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Targeted Radionuclide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Bayer Company Detail

Table 47. Bayer Business Overview

Table 48. Bayer Targeted Radionuclide Therapy Product

Table 49. Bayer Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 50. Bayer Recent Development

Table 51. Novartis Company Detail

Table 52. Novartis Business Overview

Table 53. Novartis Targeted Radionuclide Therapy Product

Table 54. Novartis Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Lantheus Company Detail

Table 57. Lantheus Business Overview

Table 58. Lantheus Targeted Radionuclide Therapy Product

Table 59. Lantheus Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 60. Lantheus Recent Development

Table 61. Aurobindo Pharma Company Detail

Table 62. Aurobindo Pharma Business Overview

Table 63. Aurobindo Pharma Targeted Radionuclide Therapy Product

Table 64. Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 65. Aurobindo Pharma Recent Development

Table 66. Mundipharma Company Detail

Table 67. Mundipharma Business Overview

Table 68. Mundipharma Targeted Radionuclide Therapy Product

Table 69. Mundipharma Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 70. Mundipharma Recent Development

Table 71. China Isotope & Radiation Company Detail

Table 72. China Isotope & Radiation Business Overview

Table 73. China Isotope & Radiation Targeted Radionuclide Therapy Product

Table 74. China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 75. China Isotope & Radiation Recent Development

Table 76. Curium Pharmaceuticals Company Detail

Table 77. Curium Pharmaceuticals Business Overview

Table 78. Curium Pharmaceuticals Targeted Radionuclide Therapy Product

Table 79. Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 80. Curium Pharmaceuticals Recent Development

Table 81. Gilead Sciences Company Detail

Table 82. Gilead Sciences Business Overview

Table 83. Gilead Sciences Targeted Radionuclide Therapy Product

Table 84. Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 85. Gilead Sciences Recent Development

Table 86. Clarity Pharmaceuticals Company Detail

Table 87. Clarity Pharmaceuticals Business Overview

Table 88. Clarity Pharmaceuticals Targeted Radionuclide Therapy Product

Table 89. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 90. Clarity Pharmaceuticals Recent Development

Table 91. Curasight Company Detail

Table 92. Curasight Business Overview

Table 93. Curasight Targeted Radionuclide Therapy Product

Table 94. Curasight Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 95. Curasight Recent Development

Table 96. Nordic Nanovector Company Detail

Table 97. Nordic Nanovector Business Overview

Table 98. Nordic Nanovector Targeted Radionuclide Therapy Product

Table 99. Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 100. Nordic Nanovector Recent Development

Table 101. Philogen Company Detail

Table 102. Philogen Business Overview

Table 103. Philogen Targeted Radionuclide Therapy Product

Table 104. Philogen Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 105. Philogen Recent Development

Table 106. RadioMedix Company Detail

Table 107. RadioMedix Business Overview

Table 108. RadioMedix Targeted Radionuclide Therapy Product

Table 109. RadioMedix Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 110. RadioMedix Recent Development

Table 111. Telix Pharmaceuticals Company Detail

Table 112. Telix Pharmaceuticals Business Overview

Table 113. Telix Pharmaceuticals Targeted Radionuclide Therapy Product

Table 114. Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 115. Telix Pharmaceuticals Recent Development

Table 116. Orano Med Company Detail

Table 117. Orano Med Business Overview

Table 118. Orano Med Targeted Radionuclide Therapy Product

Table 119. Orano Med Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 120. Orano Med Recent Development

Table 121. Actinium Pharmaceuticals Company Detail

Table 122. Actinium Pharmaceuticals Business Overview

Table 123. Actinium Pharmaceuticals Targeted Radionuclide Therapy Product

Table 124. Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 125. Actinium Pharmaceuticals Recent Development

Table 126. Y-mAbs Therapeutics Company Detail

Table 127. Y-mAbs Therapeutics Business Overview

Table 128. Y-mAbs Therapeutics Targeted Radionuclide Therapy Product

Table 129. Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 130. Y-mAbs Therapeutics Recent Development

Table 131. Fusion Pharmaceuticals Company Detail

Table 132. Fusion Pharmaceuticals Business Overview

Table 133. Fusion Pharmaceuticals Targeted Radionuclide Therapy Product

Table 134. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2019-2024) & (US$ Million)

Table 135. Fusion Pharmaceuticals Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Targeted Radionuclide Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Targeted Radionuclide Therapy Market Share by Type: 2023 VS 2030

Figure 3. Beta-emitting Features

Figure 4. Targeted Alpha Therapy Features

Figure 5. Global Targeted Radionuclide Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Targeted Radionuclide Therapy Market Share by Application: 2023 VS 2030

Figure 7. Solid Tumor Case Studies

Figure 8. Non Hodgkin Lymphoma Case Studies

Figure 9. Targeted Radionuclide Therapy Report Years Considered

Figure 10. Global Targeted Radionuclide Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Targeted Radionuclide Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Targeted Radionuclide Therapy Market Share by Region: 2023 VS 2030

Figure 13. Global Targeted Radionuclide Therapy Market Share by Players in 2023

Figure 14. Global Top Targeted Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Targeted Radionuclide Therapy Revenue in 2023

Figure 16. North America Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Targeted Radionuclide Therapy Market Share by Country (2019-2030)

Figure 18. United States Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Targeted Radionuclide Therapy Market Share by Country (2019-2030)

Figure 22. Germany Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Targeted Radionuclide Therapy Market Share by Region (2019-2030)

Figure 30. China Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Targeted Radionuclide Therapy Market Share by Country (2019-2030)

Figure 38. Mexico Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Targeted Radionuclide Therapy Market Share by Country (2019-2030)

Figure 42. Turkey Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Targeted Radionuclide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Bayer Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 45. Novartis Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 46. Lantheus Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 47. Aurobindo Pharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 48. Mundipharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 49. China Isotope & Radiation Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 50. Curium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 51. Gilead Sciences Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 52. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 53. Curasight Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 54. Nordic Nanovector Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 55. Philogen Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 56. RadioMedix Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 57. Telix Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 58. Orano Med Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 59. Actinium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 60. Y-mAbs Therapeutics Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 61. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions